Five-year survival following a medial pancreatectomy for an invasive ductal carcinoma from the body of the pancreas

被引:1
作者
Abe, Hideki
Tsuneyama, Kouichi
Tsukada, Kazuhiro
Makuuchi, Masatoshi
机构
[1] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliarypancreat Div,Bunkyo Ku, Tokyo 1138655, Japan
[2] Toyama Med & Pharmaceut Univ, Dept Pathol, Toyama, Japan
[3] Toyama Med & Pharmaceut Univ, Dept Surg 2, Toyama, Japan
关键词
ductal carcinoma; medial pancreatectomy; pancreatic carcinoma;
D O I
10.3748/wjg.v12.i5.822
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report a rare case of a patient who survived for 5 years after undergoing a medial pancreatectomy for invasive ductal carcinoma originating from the body of the pancreas. A 63-year-old woman was diagnosed as a small cancer of the pancreatic body, and surgery was performed. Even though the tumor was a carcinoma, its small size prompted us to perform a medial pancreatectomy with regional lymph nodes dissection. Additional chemoradiation was performed and, five years after surgery, the patient is well with no signs of recurrence. Medial pancreatectomy for invasive ductal carcinoma has not ever been reported. Furthermore, long-term survival after a lumpectomy for invasive ductal carcinoma has never been reported in the literatures. The current case suggests that long-term survival in patients with invasive ductal carcinoma of the pancreas may be associated with the pathological or biological features of pancreatic carcinoma. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:822 / 824
页数:3
相关论文
共 7 条
[1]
Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Clinicopathologic analysis of 5-year survivors [J].
Conlon, KC ;
Klimstra, DS ;
Brennan, MF .
ANNALS OF SURGERY, 1996, 223 (03) :273-279
[2]
Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy [J].
Fortner, JG ;
Klimstra, DS ;
Senie, RT ;
Maclean, BJ .
ANNALS OF SURGERY, 1996, 223 (02) :147-153
[3]
CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma [J].
Fukunaga, A ;
Miyamoto, M ;
Cho, Y ;
Murakami, S ;
Kawarada, Y ;
Oshikiri, T ;
Kato, K ;
Kurokawa, T ;
Suzuoki, M ;
Nakakubo, Y ;
Hiraoka, K ;
Itoh, T ;
Morikawa, T ;
Okushiba, S ;
Kondo, S ;
Katoh, H .
PANCREAS, 2004, 28 (01) :E26-E31
[4]
Adjuvant or neoadjuvant therapy for pancreatic carcinoma? [J].
Jeekel, J .
DIGESTION, 1997, 58 (06) :533-535
[5]
Treatment of pancreatic cancer:: The role of surgery [J].
Ozawa, F ;
Friess, H ;
Künzli, B ;
Shrikhande, SV ;
Otani, T ;
Makuuchi, M ;
Büchler, MW .
DIGESTIVE DISEASES, 2001, 19 (01) :47-56
[6]
Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas -: A multicenter, prospective, randomized study [J].
Pedrazzoli, S ;
DiCarlo, V ;
Dionigi, R ;
Mosca, F ;
Pederzoli, P ;
Pasquali, C ;
Klöppel, G ;
Dhaene, K ;
Michelassi, F .
ANNALS OF SURGERY, 1998, 228 (04) :508-514
[7]
ROTMAN N, 1993, SURGERY, V113, P532